News - Page 202

TLDR: Curie.Bio has raised $380 million to support early-stage biotech founders for better long-term results. The VC firm offers seed money for series A rounds to help companies with clinical proof-of-concept studies.

Summary of “Is the revival of Paris in peril?” TLDR: Paris has recently experienced a commercial renaissance, attracting global businessmen and investors. French President Emmanuel Macron’s ambition to make France more innovative

TLDR: BillionToOne, a diagnostic developer, has reached a billion-dollar valuation with a $130 million funding round. The funding will be used to expand DNA testing businesses in prenatal screening and cancer. Diagnostic

TLDR: Stony Lonesome Group, a venture capital firm, announced a strategic partnership with Freedom First Corp, a subsidiary of RTB Ventures. This partnership includes a capital commitment from Freedom First as the

TLDR: State-backed funds in China are focusing on developing “patient capital” to strengthen technological self-reliance. This capital aims for long-term returns rather than quick profits. The government is looking to nurture State-owned

TLDR: Bangladesh Venture Capital Limited invests Tk2.5 crore in Chaldal Limited and Sokrio Technologies Limited. The investment is aimed at promoting the growth of the startups and nurturing the next generation of

TLDR: New Ventures, led by Rodrigo Villar, is focusing on niche impact investing with specialized financing vehicles for specific challenges. The organization runs accelerators in Latin America, has a lending facility, and

TLDR: Zuub secures $9 million in Series A funding to transform dental revenue cycle automation Funding will enable Zuub to develop innovative solutions using AI and automation technologies to streamline dental practice

TLDR: Venture capitalists are shifting towards supporting Trump due to Biden’s proposed wealth tax. The alliance between Democrats and venture capitalists has shaped the US innovation financing model. Silicon Valley venture capitalists

TLDR: Gender bias remains a significant challenge in European venture capital, with only 15% of firms having women investment decision-makers. CapitalT, led by Janneke Niessen and Eva de Mol, uses innovative strategies